IN190590B - - Google Patents

Info

Publication number
IN190590B
IN190590B IN1127DE2001A IN190590B IN 190590 B IN190590 B IN 190590B IN 1127DE2001 A IN1127DE2001 A IN 1127DE2001A IN 190590 B IN190590 B IN 190590B
Authority
IN
India
Prior art keywords
cells
coli
followed
dh5alpha
anthrax
Prior art date
Application number
Other languages
English (en)
Inventor
Rakesh Bhatnagar
Syed Mohsin Waheed
Vibha Chauhan
Original Assignee
Rakesh Bhatnagar
Syed Mohsin Waheed
Vibha Chauhan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to UA20040503327A priority Critical patent/UA80809C2/uk
Application filed by Rakesh Bhatnagar, Syed Mohsin Waheed, Vibha Chauhan filed Critical Rakesh Bhatnagar
Priority to IN1127DE2001 priority patent/IN190590B/en
Priority to PCT/IN2001/000215 priority patent/WO2003040179A1/en
Priority to CA002465679A priority patent/CA2465679A1/en
Priority to JP2003542224A priority patent/JP2005510215A/ja
Priority to CNB018239226A priority patent/CN100347189C/zh
Priority to MXPA04004281A priority patent/MXPA04004281A/es
Priority to BRPI0117173A priority patent/BRPI0117173A2/pt
Priority to IL16172501A priority patent/IL161725A0/xx
Priority to US10/494,680 priority patent/US7329513B2/en
Priority to RU2004117085/13A priority patent/RU2288272C2/ru
Priority to DE60143276T priority patent/DE60143276D1/de
Priority to EP01274653A priority patent/EP1442052B1/de
Priority to AT01274653T priority patent/ATE484517T1/de
Priority to HK05105241.1A priority patent/HK1072610B/xx
Publication of IN190590B publication Critical patent/IN190590B/en
Priority to ZA200403396A priority patent/ZA200403396B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Laminated Bodies (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IN1127DE2001 2001-11-05 2001-11-05 IN190590B (de)

Priority Applications (16)

Application Number Priority Date Filing Date Title
UA20040503327A UA80809C2 (en) 2001-11-05 2001-07-12 Process for preparation of protective antigen protein of anthracis with e.coli
IN1127DE2001 IN190590B (de) 2001-11-05 2001-11-05
BRPI0117173A BRPI0117173A2 (pt) 2001-11-05 2001-12-07 produção constituida de alto nível de antígeno protetor para antraz
US10/494,680 US7329513B2 (en) 2001-11-05 2001-12-07 High level constitutive production of anthrax protective antigen
JP2003542224A JP2005510215A (ja) 2001-11-05 2001-12-07 炭疽防御抗原の高レベルでの構成的生成
CNB018239226A CN100347189C (zh) 2001-11-05 2001-12-07 炭疽保护抗原的高水平组成性生产
MXPA04004281A MXPA04004281A (es) 2001-11-05 2001-12-07 Produccion consitutiva de alto nivel de antigeno protector de antrax.
PCT/IN2001/000215 WO2003040179A1 (en) 2001-11-05 2001-12-07 High level constitutive production of anthrax protective antigen
IL16172501A IL161725A0 (en) 2001-11-05 2001-12-07 A process for preparing an anthrax protective antigen
CA002465679A CA2465679A1 (en) 2001-11-05 2001-12-07 High level constitutive production of anthrax protective antigen
RU2004117085/13A RU2288272C2 (ru) 2001-11-05 2001-12-07 Высокие уровни конститутивного продуцирования защитного антигена сибирской язвы
DE60143276T DE60143276D1 (de) 2001-11-05 2001-12-07 Höhe konstitutive produktion von anthrax oberflächenschutzantigen
EP01274653A EP1442052B1 (de) 2001-11-05 2001-12-07 Höhe konstitutive produktion von anthrax oberflächenschutzantigen
AT01274653T ATE484517T1 (de) 2001-11-05 2001-12-07 Höhe konstitutive produktion von anthrax oberflächenschutzantigen
HK05105241.1A HK1072610B (en) 2001-11-05 2001-12-07 High level constitutive production of anthrax protective antigen
ZA200403396A ZA200403396B (en) 2001-11-05 2004-05-05 High level constitutive production of anthrax protective antigen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1127DE2001 IN190590B (de) 2001-11-05 2001-11-05

Publications (1)

Publication Number Publication Date
IN190590B true IN190590B (de) 2003-08-09

Family

ID=11097131

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1127DE2001 IN190590B (de) 2001-11-05 2001-11-05

Country Status (15)

Country Link
US (1) US7329513B2 (de)
EP (1) EP1442052B1 (de)
JP (1) JP2005510215A (de)
CN (1) CN100347189C (de)
AT (1) ATE484517T1 (de)
BR (1) BRPI0117173A2 (de)
CA (1) CA2465679A1 (de)
DE (1) DE60143276D1 (de)
IL (1) IL161725A0 (de)
IN (1) IN190590B (de)
MX (1) MXPA04004281A (de)
RU (1) RU2288272C2 (de)
UA (1) UA80809C2 (de)
WO (1) WO2003040179A1 (de)
ZA (1) ZA200403396B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117093572A (zh) * 2023-08-24 2023-11-21 中国建设银行股份有限公司 数据补录方法、装置、设备、存储介质及产品

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80809C2 (en) * 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
CN1833030B (zh) 2003-05-22 2014-07-23 美国弗劳恩霍夫股份有限公司 用于表达、传递及纯化目标多肽的重组载体分子
AU2003271835A1 (en) * 2003-06-06 2005-01-04 Avecia Limited Process for the separation of proteins
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
US8101735B2 (en) 2004-06-16 2012-01-24 Health Protection Agency Preparation of protective antigen
CN100336908C (zh) * 2004-09-10 2007-09-12 中国人民解放军军事医学科学院微生物流行病研究所 一种制备重组炭疽保护性抗原的方法及其专用表达质粒
EP1919504B1 (de) 2005-08-03 2013-10-16 iBio, Inc. Antikörper gegen bacillus anthracis protektiv antigen
WO2008048344A2 (en) * 2006-02-13 2008-04-24 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
US8124103B2 (en) 2006-02-13 2012-02-28 Fraunhofer Usa, Inc Influenza antigens, vaccine compositions, and related methods
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
CA2651962A1 (en) * 2006-05-12 2007-12-21 Oklahoma Medical Research Foundation Anthrax compositions and methods of use and production
WO2008115198A2 (en) 2006-06-30 2008-09-25 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates,synthesis and uses thereof
US8420607B2 (en) 2006-06-30 2013-04-16 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates, synthesis and uses thereof
US8404252B2 (en) 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
WO2009126355A2 (en) * 2008-01-28 2009-10-15 Baxter International, Inc. Methods of increasing recombinant production of bacillus anthracis protective antigen
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
CA2738621C (en) 2008-10-02 2017-01-31 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
US20100183675A1 (en) * 2009-01-22 2010-07-22 Allan Watkinson Stable vaccine compositions and methods of use
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
US20120301951A1 (en) * 2010-11-18 2012-11-29 E. I. Du Pont De Nemours And Company Prevention of contamination of nutrient feed reservoirs & feed lines in bioreactor systems
RU2633504C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E.coli - продуцент полноразмерного протективного антигена Bacillus anthracis в форме вирусоподобных частиц
RU2633508C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E. coli - продуцент изолированного домена 1 протективного антигена Bacillus anthracis в форме вирусоподобных частиц
CN115125224B (zh) * 2022-08-11 2023-07-18 福州大学 一种可规模化生产具有活性的dna聚合酶的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591631A (en) * 1993-02-12 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Anthrax toxin fusion proteins, nucleic acid encoding same
US5677274A (en) * 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
US5800821A (en) * 1995-03-10 1998-09-01 New England Medical Center Hospitals, Inc. Bacterial spores as a heat stable vaccine delivery system
GB9618107D0 (en) * 1996-08-30 1996-10-09 Secr Defence Vaccine production
ATE284957T1 (de) * 1998-04-07 2005-01-15 Wisconsin Alumni Res Found Enterotoxindefizierende bacillus
US20020086032A1 (en) * 1999-02-02 2002-07-04 Mahan Michael J. Producing antibodies with attenuated bacteria with altered DNA adenine methylase activity
WO2003055977A2 (en) * 2001-10-01 2003-07-10 Regents Of The University Of California A method for generating overexpression of alleles in genes of unknown function
UA80809C2 (en) * 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
US7763451B2 (en) * 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117093572A (zh) * 2023-08-24 2023-11-21 中国建设银行股份有限公司 数据补录方法、装置、设备、存储介质及产品

Also Published As

Publication number Publication date
CN100347189C (zh) 2007-11-07
HK1072610A1 (zh) 2005-09-02
IL161725A0 (en) 2005-11-20
EP1442052B1 (de) 2010-10-13
WO2003040179A1 (en) 2003-05-15
UA80809C2 (en) 2007-11-12
CN1582298A (zh) 2005-02-16
DE60143276D1 (de) 2010-11-25
US7329513B2 (en) 2008-02-12
ZA200403396B (en) 2005-08-05
BRPI0117173A2 (pt) 2018-04-17
US20050054038A1 (en) 2005-03-10
RU2288272C2 (ru) 2006-11-27
ATE484517T1 (de) 2010-10-15
JP2005510215A (ja) 2005-04-21
MXPA04004281A (es) 2005-03-31
EP1442052A1 (de) 2004-08-04
RU2004117085A (ru) 2005-03-27
CA2465679A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
IL161725A0 (en) A process for preparing an anthrax protective antigen
Reif et al. Semisynthesis of biologically active glycoforms of the human cytokine interleukin 6
Verma et al. Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems
CA2417415A1 (en) Expression of biologically active polypeptides in duckweed
IL155482A0 (en) Metabolic rate shifts in fermentations expressing recombinant proteins
CN107532190A (zh) 用于肽生产的融合伴侣
NZ335628A (en) Improved expression vectors comprising a nucleic acid construct with tac and gal bacterial promoters
EP0737747A3 (de) Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragment-Fusionsmolekülen in E. coli
CN104066841B (zh) 表达载体和蛋白质的制造方法
CN102659928B (zh) 一种人工合成的信号肽及其应用
KR100614020B1 (ko) 폴리펩티드의 재조합 생산을 위한 향상된 방법
Lee et al. Novel secretion system of recombinant Saccharomyces cerevisiae using an N‐terminus residue of human IL‐1β as secretion enhancer
Kawasaki et al. Folding-Dependentin VitroProtein Splicing of theSaccharomyces cerevisiae VMA1Protozyme
CN101538318B (zh) 一种信号肽及其编码基因与应用
CN103483423B (zh) 一种人工合成的信号肽及其应用
JP2540039B2 (ja) プラスミドベクタ−
Schnappinger et al. Extracellular expression of native human anti-lysozyme fragments in Staphylococcus carnosus
CN101921315B (zh) 一种人工合成的信号肽及其应用
CA2082802C (en) Method for expressing polypeptides in cyanobacteria
Bahrami et al. Production of recombinant human granulocyte-colony stimulating factor by Pichia pastoris
Kunes et al. Expression of antibodies using single‐open reading frame vector design and polyprotein processing from mammalian cells
CN102659927B (zh) 一种人工合成的信号肽及其应用
AU7128294A (en) Family of peptides known as xenoxins
CN104059128B (zh) 一种人工合成的信号肽及其应用
KR920009502B1 (ko) 인간 초산화물 불균화 효소(Cu, Zn-SOD) 발현운반체 (pYLBC-A/G-SOD) 및 그의 제조방법